Your browser doesn't support javascript.
loading
Non-clinical safety and biodistribution of AS03-adjuvanted inactivated pandemic influenza vaccines.
Segal, Lawrence; Wouters, Sandrine; Morelle, Danielle; Gautier, Gaëlle; Le Gal, Julien; Martin, Thomas; Kuper, Frieke; Destexhe, Eric; Didierlaurent, Arnaud M; Garçon, Nathalie.
Afiliação
  • Segal L; GSK Vaccines, Rue de l'Institut 89, 1330, Rixensart, Belgium.
  • Wouters S; GSK Vaccines, Rue de l'Institut 89, 1330, Rixensart, Belgium.
  • Morelle D; GSK Vaccines, Rue de l'Institut 89, 1330, Rixensart, Belgium.
  • Gautier G; Chelatec SAS, 1 rue Aronnax, 44821, Saint-Herblain Cedex, France.
  • Le Gal J; Chelatec SAS, 1 rue Aronnax, 44821, Saint-Herblain Cedex, France.
  • Martin T; Covance Laboratories Ltd., Otley Road, Harrogate, HG3 1PY, England.
  • Kuper F; TNO, Utrechtseweg 48, NL-3700, AJ, Zeist, The Netherlands.
  • Destexhe E; GSK Vaccines, Rue de l'Institut 89, 1330, Rixensart, Belgium.
  • Didierlaurent AM; GSK Vaccines, Rue de l'Institut 89, 1330, Rixensart, Belgium.
  • Garçon N; GSK Vaccines, Rue de l'Institut 89, 1330, Rixensart, Belgium.
J Appl Toxicol ; 35(12): 1564-76, 2015 Dec.
Article em En | MEDLINE | ID: mdl-25727696

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2015 Tipo de documento: Article